Amylin Pharmaceuticals To Present New Data And Insights From The Company's Diabetes Programs At ADA 2010
Links shared publicly online about this topic.
- 1,083total visits
Amylin Pharmaceuticals To Present New Data And Insights From The Company's Diabetes Programs At ADA 2010
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced that the Company will present data for its FDA-approved diabetes drugs, BYETTA® (exenatide) injection and SYMLIN® (pramlintide acetate
View full resource at medicalnewstoday.com
Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Pharma, Byetta
Most Recently Shared on June 21, 2010 at 2:04 am By:
Amylin Pharmaceuticals To Present New Data And Insights From The Company's Diabetes Programs At ADA 2010: http://bit.ly/ch6DCM
Also Shared By:
Advertisement
MNT Diabetes News
@mnt_diabetes
Amylin Pharmaceuticals To Present New Data And Insights From The Company's Diabetes Programs At ADA 2010 http://mnt.to/3F6w #diabetes
1 year ago...